 REHOVOT, Israel, Feb. 10, 2021 GLOBE NEWSWIRE -- Kamada Ltd. NASDAQ: KMDA; TASE: KMDA.TA, a plasma-derived biopharmaceutical company, today announced financial results for the three and 12 months ended December 31, 2020. 